Philanthropists Jim and Eleanor Randall and the Randall Family Foundation have given a transformative $100 million gift to the Cedars-Sinai Department of Surgery to propel innovation in surgical care, training and research.
Shlomo Melmed, MB, ChB, executive vice president of Medicine and Health Sciences and dean of the Medical Faculty at Cedars-Sinai, has received the Pituitary Society’s top honor for his four decades of pioneering achievements and leadership in the field of endocrinology.
Deep brain stimulation procedures use electrical pulses to disrupt tiny portions of the brain and halt epileptic seizures or disease-related tremor. The therapy is invaluable, but the basic technology has not advanced in decades.
Vita Rose Carletti made her grand entry into the world on Jan. 7, 2024, after her mother, Krista Hazelwood, went through an arduous 36-hour labor that ended in an emergency cesarean section.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
The choices that Bruce Gold faced last December to resolve debilitating symptoms from a severely enlarged prostate were to keep using a catheter or have an invasive surgery with unreliable results and a high risk of complications and lingering side effects.
Cedars-Sinai’s History of Medicine Program will host a free event, open to the public, to commemorate the 80th anniversary of D-Day and discuss the important role of American medicine in World War II.
Endocrinologists from Cedars-Sinai will present research findings and discuss advances in clinical care throughout ENDO 2024, the Endocrine Society’s annual meeting in Boston, June 1-4.
Cedars-Sinai geriatricians, geroscience investigators and experts in memory disorders and orthopedics will be among the presenters at the inaugural conference of the California Academic Geriatrics Institutions on May 31 at the University of California, Irvine.
Cedars-Sinai has promoted three key executives, Heitham Hassoun, MD; James Laur, JD; and Stella Chen, CPA. The promotions support Cedars-Sinai’s ongoing efforts to provide quality patient care on an international scale, create innovative business opportunities and achieve its long-term financial goals.
Cedars-Sinai Cancer physician-scientists and thought leaders will discuss scientific advances, new therapies, and the future of cancer care at the American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31-June 4 in Chicago.
Ten Cedars-Sinai nurses have been honored in a first-of-its-kind recognition by the Simms/Mann Family Foundation’s Off the Chart: Rewarding Nursing Greatness campaign.
Scientists with Cedars-Sinai Guerin Children’s, the University of California, San Francisco (UCSF), and other institutions have identified the critical first steps in how the digestive system develops.
Joshua I. Goldhaber, MD, a nationally regarded physician-scientist who has devoted much of his career to physician training and mentoring, has been named vice dean of Graduate Education.
How do you know you’re having a stroke? Know the symptoms, says Shlee S. Song, MD, director of the Comprehensive Stroke Center and the Telestroke Program at Cedars-Sinai.
Cedars-Sinai digestive and liver diseases physicians and scientists will share their latest research at the annual Digestive Disease Week meeting, that takes place May 18-21, in Washington, D.C.
Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.
Michelle Usher knew something was wrong when she became too tired to hold a paint brush or read a book. The avid oil painter and voracious reader could devour 100 novels and memoirs a year until late 2022, when overwhelming exhaustion set in.
Cedars-Sinai has named Stephanie Cohen as its new vice president of Government and Industry Relations. Cohen will play a vital role advocating for healthcare delivery, research, education and community benefit priorities with local, state and national policymakers.
Investigators from the Smidt Heart Institute at Cedars-Sinai are presenting more than 40 original research studies at the Heart Rhythm Society annual meeting in Boston, May 16-19.
Duaa Jabari, MD, a neuromuscular medicine specialist with a particular interest in autoimmune neuromuscular disorders and neuromuscular pathology, has joined the Cedars-Sinai Department of Neurology as director of Electromyography.
Cedars-Sinai Cancer has selected radiation oncology physicist Indrin Chetty, PhD, as the new vice chair of Research and director of the Medical Physics Division in the Department of Radiation Oncology.
Cedars-Sinai’s chief health equity officer will be available for interviews during the American Hospital Association: Accelerating Health Equity Conference, May 7-9 in Kansas City.
Cedars-Sinai investigators are using artificial intelligence (AI) to reduce serious health risks associated with pregnancy and childbirth and improve screening for some gynecological cancers.
Cedars-Sinai experts are participating in the inaugural Abu Dhabi Global Healthcare Week, May 13-15 in Abu Dhabi, United Arab Emirates, highlighting their dedication to enhancing innovation and medical advances that will have a positive impact on communities worldwide.
It was Pearl Berg’s birthday, and a TV reporter asked her what some might consider a rhetorical question. “Mrs. Berg,” he said, “how did you get to be 107 years old?” She looked up from her seat and with a twinkle in her eye, she answered. “Well … first, you have to be 106.”
Cedars-Sinai remembers. On Yom Ha’Shoah, also known as Holocaust Remembrance Day, the medical center solemnly honored the six million Jews, and millions of others, who perished under Nazi rule, one of the darkest periods in history.
An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their Cedars-Sinai colleagues can detect a type of abnormal heart rhythm that can go unnoticed during medical appointments, according to a new study.
What can a Jewish hospital learn from World War II-era medical experiments carried out by Nazis? A lot, as it turns out.
Paul Noble, MD, professor of Medicine at Cedars-Sinai and a leading physician-scientist in pulmonary fibrosis, recently began his one-year term as president of the highly regarded Association of American Physicians (AAP) at the group’s annual meeting in Chicago.
The Cedars-Sinai Accelerator and Technology Ventures teams, together with Coronet Ventures (Singapore) Pte. Ltd., a subsidiary of Cedars-Sinai Intellectual Property Company, will host 11 startup companies from Singapore during the Singapore Innovation Week event, May 6-10 in Los Angeles.
The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, is teaming up with the AIM at Melanoma Foundation for the 14th year to host a free melanoma symposium for patients, caregivers and clinicians.
Physician-scientists from the Department of Urology at Cedars-Sinai will be attending the American Urological Association (AUA) Annual Meeting May 3-6 in San Antonio, Texas, and are available to discuss the latest research and innovations in urological care.
Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac ultrasound videos, and their corresponding clinical interpretations. Using this database, they created EchoCLIP, a powerful machine learning algorithm that can “interpret” echocardiogram images and assess key findings.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for April 2024.
Cedars-Sinai Guerin Children’s pediatric oncologist Leo Mascarenhas, MD, MS, has been reelected as Children’s Oncology Group (COG) voting body chair for a second five-year term.
Charles Schulz and his wife, Flor, sat in their living room on New Year’s Eve 2023, watching TV and counting down the seconds until the ball dropped in New York’s Times Square.
Cedars-Sinai is marking Patient Experience Week 2024 with activities to honor team members and the impact they make in the lives of patients every day.
Surgeons from the Smidt Heart Institute at Cedars-Sinai will be attending the American Association for Thoracic Surgery (AATS) Annual Meeting April 27-30 in Toronto and are available to discuss the latest cardiac surgery news and research.
Ageless and evergreen: The signature lyric that sums up Robin Lipman’s reverence for one of the most iconic entertainers of our time. That epic level of fan appreciation would manifest in a fundraising campaign to benefit the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute at Cedars-Sinai.
Investigators in the Smidt Heart Institute at Cedars-Sinai and colleagues report that women with Type 2 diabetes diagnosed with hypertension before age 50 may benefit from intensive blood pressure treatment.
A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography (CT) scan without contrast.
Cedars-Sinai investigators have identified significant variations in the microbes of the small bowel (small intestine) are strongly associated with various body weights, from a normal body mass index, or BMI, to having obesity.
Cedars-Sinai investigators have discovered how brain cells responsible for working memory—the type required to remember a phone number long enough to dial it—coordinate intentional focus and short-term storage of information.
Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment.
Every day, scientists across Cedars-Sinai’s vast research and clinical enterprise are focused on developing medical discoveries and breakthroughs to improve health outcomes.
Bin Zheng, PhD, a specialist in targeted therapies and immunotherapy, has joined Cedars-Sinai Cancer as director of Melanoma Research in the Department of Biomedical Sciences. Zheng will work with Cedars-Sinai surgical and medical oncology leadership to develop and lead a comprehensive translational and basic science research program for melanoma.
Neuroprosthetics, a technology that allows the brain to control external devices such as robotic limbs, is beginning to emerge as a viable option for patients disabled by amputation or neurological conditions such as stroke.
Cedars-Sinai está ampliando la atención médica virtual para niños e hispanohablantes en California a través de su aplicación móvil Cedars-Sinai Connect, una opción en línea de rápido crecimiento que permite a los pacientes acceder rápidamente a los mejores profesionales sanitarios para la atención aguda, crónica y preventiva.
Cedars-Sinai has joined a White House initiative aimed at ensuring healthcare providers and companies use artificial intelligence (AI) ethically and responsibly. Together with the U.S. Department of Health and Human Services, the AI effort—announced in late 2023—is a consortium involving nearly 40 health systems and insurers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
